povorcitinib - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of Tesco PLC’s supermarket and financial performance theme after the retailer reported £3.15bn adjusted operating profit, record free cash flow, and a new £750m share buyback.

Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention

Representative image of military and commercial vessels near the Strait of Hormuz, illustrating Iran’s renewed control measures after reversing its brief claim that the waterway was fully open to commercial shipping.

Iran reverses Hormuz opening within 24 hours — IRGC fires on tankers as blockade standoff deepens

Representative image of a legal and workplace rights dispute in India after the National Human Rights Commission notices and the Supreme Court filing intensified focus on the Nashik workplace harassment and coercion case involving Tata Consultancy Services.

TCS Nashik case: NHRC directs three-year POSH audit across all TCS branches

Nexstar Media Group (NASDAQ: NXST) faces post-closing merger shock as judge halts TEGNA integration

Representative image of oral hidradenitis suppurativa treatment research as Incyte Corporation reports positive 54-week povorcitinib Phase 3 data, highlighting the race to expand HS therapy options.

Read More

Pharma Industry News

Incyte (NASDAQ: INCY) moves closer to an hidradenitis suppurativa launch as 54-week povorcitinib data hold up

Incyte Corporation’s new 54-week povorcitinib data could reshape hidradenitis suppurativa treatment. Read what it means for INCY now.

byPallavi Madhiraju

March 29, 2026

web analytics